Search research articles
Contact Us
Filters
Showing results (171-180 of 517) with videos related to
Page
of 52
Sort By:
Circulation
|
October 1, 1996
Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis
T J Shetler, V G Crowe, B D Bailey, et al.
Peptides
|
June 28, 2005
Corticotropin-releasing factor from the rat brain measured by protein immunoblot
Edward G Meloni, Alexandra V Jackson, Bruce M Cohen, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1985
Increased plasma noradrenaline during low dose adrenaline infusion in resting man and during sympathetic stimulation
I F Musgrave, A W Bachmann, R V Jackson, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1989
Nifedipine blocks ACTH and cortisol release in man
R V Jackson, A J Jackson, J E Grice, et al.
The American Journal of Psychiatry
|
November 1, 1979
Treatment of tardive dyskinesia with lecithin
I V Jackson, E A Nuttall, I O Ibe, et al.
Neuroreport
|
April 1, 1992
CRH-mediated pituitary-adrenal responses are inhibited by nifedipine in humans
J E Grice, G I Hockings, A J Jackson, et al.
Inflammation
|
June 13, 2000
Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model
J S Fine, J V Jackson, A Rojas-Triana, et al.
Cancer Research
|
March 1, 1980
Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates
D V Jackson, M C Castle, D G Poplack, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Synergistic antitumor activity of vincristine and VP-16-213
D V Jackson, T R Long, T F Trahey, et al.
Biological Psychiatry
|
January 1, 1981
Lecithin administration in tardive dyskinesia: clinical and biomedical correlates
I V Jackson, L G Davis, R K Cohen, et al.
Page
of 52
Search research articles
Search
Showing results (171-180 of 517) with videos related to
Sort By:
Page
of 52
Circulation
|
October 1, 1996
Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis
T J Shetler, V G Crowe, B D Bailey, et al.
Peptides
|
June 28, 2005
Corticotropin-releasing factor from the rat brain measured by protein immunoblot
Edward G Meloni, Alexandra V Jackson, Bruce M Cohen, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1985
Increased plasma noradrenaline during low dose adrenaline infusion in resting man and during sympathetic stimulation
I F Musgrave, A W Bachmann, R V Jackson, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1989
Nifedipine blocks ACTH and cortisol release in man
R V Jackson, A J Jackson, J E Grice, et al.
The American Journal of Psychiatry
|
November 1, 1979
Treatment of tardive dyskinesia with lecithin
I V Jackson, E A Nuttall, I O Ibe, et al.
Neuroreport
|
April 1, 1992
CRH-mediated pituitary-adrenal responses are inhibited by nifedipine in humans
J E Grice, G I Hockings, A J Jackson, et al.
Inflammation
|
June 13, 2000
Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model
J S Fine, J V Jackson, A Rojas-Triana, et al.
Cancer Research
|
March 1, 1980
Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates
D V Jackson, M C Castle, D G Poplack, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Synergistic antitumor activity of vincristine and VP-16-213
D V Jackson, T R Long, T F Trahey, et al.
Biological Psychiatry
|
January 1, 1981
Lecithin administration in tardive dyskinesia: clinical and biomedical correlates
I V Jackson, L G Davis, R K Cohen, et al.
Page
of 52